ArticleArthritis research & therapy2021

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod.

Roger Hesselstrand et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.